lysophosphatidate

ectonucleotide pyrophosphatase/phosphodiesterase 2 ; Homo sapiens







14 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32305571 Role of the autotaxin-lysophosphatidate axis in the development of resistance to cancer therapy. 2020 Aug 3
2 32451553 Signalling by lysophosphatidate and its health implications. 2020 Sep 23 2
3 30192654 Dexamethasone decreases the autotaxin-lysophosphatidate-inflammatory axis in adipose tissue: implications for the metabolic syndrome and breast cancer. 2019 Feb 2
4 31035435 Expression of Autotaxin⁻Lysophosphatidate Signaling-Related Proteins in Breast Cancer with Adipose Stroma. 2019 Apr 29 1
5 31455351 Expression of proteins related to autotaxin-lysophosphatidate signaling in thyroid tumors. 2019 Aug 28 3
6 28347252 The critical role and potential target of the autotaxin/lysophosphatidate axis in pancreatic cancer. 2017 Mar 4
7 28539367 Implications for breast cancer treatment from increased autotaxin production in adipose tissue after radiotherapy. 2017 Sep 1
8 26037280 Autotaxin is an inflammatory mediator and therapeutic target in thyroid cancer. 2015 Aug 1
9 24560789 Autotaxin in the crosshairs: taking aim at cancer and other inflammatory conditions. 2014 Aug 19 2
10 25195735 The role and therapeutic potential of the autotaxin-lysophosphatidate signalling axis in breast cancer. 2014 Oct 1 2
11 22954454 Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy. 2013 Jan 2
12 21647386 Lysophosphatidate induces chemo-resistance by releasing breast cancer cells from taxol-induced mitotic arrest. 2011 2
13 19079345 Autotaxin protects MCF-7 breast cancer and MDA-MB-435 melanoma cells against Taxol-induced apoptosis. 2009 Feb 19 1
14 19204929 Inhibition of autotaxin production or activity blocks lysophosphatidylcholine-induced migration of human breast cancer and melanoma cells. 2009 Sep 2